This combination boosts the presence of CD4<sup>+</sup> and CD8<sup>+</sup> tumor-infiltrating lymphocytes, reprograms tumor-associated macrophages toward an M1-like phenotype, and improves tumor control and metastasis reduction. Here, CD4 is linked to neoplasm.